EnWave Announces Changes to its Equipment Purchase Agreement with The Green Organic Dutchman
EnWave Corporation (TSX-V:ENW | FSE:E4U) ("EnWave", or the "Company") announced today that it has agreed to modify its Equipment Purchase Agreement with Medican Organic Inc., a subsidiary of The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) ("TGOD"), that was previously announced on March 26, 2019 (the "Purchase Agreement"). Under the terms of the original Purchase Agreement, TGOD purchased three 120kW Radiant Energy Vacuum ("REV(TM)" ) machines equipped with Optional Support Equipment and Robotic Arms for installation at its Valleyfield, Quebec facility. At the request of TGOD, due to its revised processing requirements and a phasing of the Valleyfield facility buildout, the capacity of REV(TM) machinery to be delivered to TGOD has been reduced to a single 120kW REV(TM) machine with an Optional Support Equipment and Robotic Arm system. TGOD has already taken possession of a 60kW REV(TM) machine for processing at its Ancaster, Ontario facility, which is slated for commissioning in the coming months.
Cannabis Investors are Quickly Eyeing Big Opportunity in Europe
Europe may soon surpass the U.S. with regards to cannabis, says International Cannabis Conference (ICBC) founder, Alex Rogers, as noted by Leafly. "Luxembourg is about to legalize, Switzerland is about to legalize. Germany is only three to five years away from legalization. The European market is going to be bigger than the US market, one day," he says. Plus, according to market research firm, Reportlinker, "cannabinoid testing in Europe is likely to have a positive impact on the growth of the Europe cannabis testing market in the coming years. The growing number of countries are adopting medical cannabis laws but the governmental officials are rare that encouraging healthcare professionals to become educated about cannabis plant medicines." That's creating sizable opportunity for companies including Terrace Global Inc. (TSX-V:TRCE), The Green Organic Dutchman (TSX:TGOD)(OTCQX:TGODF), PharmaCielo Ltd. (OTCQX:PCLOF)(TSX-V:PCLO), Tilray Inc. (NASDAQ:TLRY), and Aphria Inc. (NYSE:APHA)(TSX:APHA).
CBD Edibles Companies are Struggling to Keep up With Consumer Demand
Thanks to Cannabis 2.0, companies are selling out of CBD edibles - and fast. So much so,the Toronto Sun refers to it as "Edibles Madness." The Ontario Cannabis Store website, for example, saw so much demand, the site crashed several times, while soft-chew items like gummies sold out in less than a half hour. Better,analysts at Deloitte, "The edibles market alone is estimated to be worth at least $1.6 billion a year in Canada, with cannabis-infused beverages adding a further $529 million," said Jennifer Lee, a partner and Deloitte Canada's Cannabis National Leader, and Consumer Advisory and Analytics Practice National Leader. "According to our research and stakeholder interviews, much of this economic boost will be on top of current cannabis product spending. The introduction of cannabis-infused edibles will clearly threaten the alcohol industry as consumers are using the product for similar usage occasions." That's opening a wide range of opportunity for companies including Naturally Splendid Enterprises Ltd. (TSX-V:NSP)(OTCQB:NSPDF), The Green Organic Dutchman Holdings Ltd. (TSX:TGOD)(OTCQX:TGODF), Curaleaf Holdings Inc. (CSE:CURA)(OTCQX:CURLF), Green Thumb Industries Inc. (CSE:GTII) (OTCQX:GTBIF), and Green Growth Brands Inc. (CSE:GGB)(OTCQB:GGBXF).